Zevra Therapeutics Inc (ZVRA)
4.805
+0.07
(+1.48%)
USD |
NASDAQ |
May 03, 16:00
4.805
0.00 (0.00%)
After-Hours: 19:31
Zevra Therapeutics Price to Book Value: 3.251 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 3.203 |
| May 01, 2024 | 3.112 |
| April 30, 2024 | 3.098 |
| April 29, 2024 | 3.078 |
| April 26, 2024 | 3.058 |
| April 25, 2024 | 3.058 |
| April 24, 2024 | 3.085 |
| April 23, 2024 | 3.098 |
| April 22, 2024 | 3.092 |
| April 19, 2024 | 3.058 |
| April 18, 2024 | 3.044 |
| April 17, 2024 | 3.139 |
| April 16, 2024 | 3.227 |
| April 15, 2024 | 3.237 |
| April 12, 2024 | 3.247 |
| April 11, 2024 | 3.342 |
| April 10, 2024 | 3.328 |
| April 09, 2024 | 3.200 |
| April 08, 2024 | 3.342 |
| April 05, 2024 | 3.261 |
| April 04, 2024 | 3.322 |
| April 03, 2024 | 3.403 |
| April 02, 2024 | 3.460 |
| April 01, 2024 | 3.491 |
| March 28, 2024 | 3.924 |
| Date | Value |
|---|---|
| March 27, 2024 | 4.018 |
| March 26, 2024 | 3.870 |
| March 25, 2024 | 3.815 |
| March 22, 2024 | 3.897 |
| March 21, 2024 | 3.921 |
| March 20, 2024 | 4.055 |
| March 19, 2024 | 3.995 |
| March 18, 2024 | 4.002 |
| March 15, 2024 | 4.028 |
| March 14, 2024 | 4.129 |
| March 13, 2024 | 4.216 |
| March 12, 2024 | 4.190 |
| March 11, 2024 | 4.116 |
| March 08, 2024 | 4.096 |
| March 07, 2024 | 4.236 |
| March 06, 2024 | 4.196 |
| March 05, 2024 | 3.968 |
| March 04, 2024 | 4.176 |
| March 01, 2024 | 4.753 |
| February 29, 2024 | 4.525 |
| February 28, 2024 | 4.606 |
| February 27, 2024 | 4.666 |
| February 26, 2024 | 4.612 |
| February 23, 2024 | 4.451 |
| February 22, 2024 | 4.565 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.139
Minimum
May 11 2022
5.753
Maximum
Jun 23 2021
2.518
Average
2.445
Median
Nov 12 2021
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 14.13 |
| Dare Bioscience Inc | -- |
| OptiNose Inc | -- |
| Kodiak Sciences Inc | 0.7462 |
| INmune Bio Inc | 5.499 |
Price to Book Value Related Metrics
| PS Ratio | 6.326 |
| PEG Ratio | -0.0569 |
| Price | 4.805 |
| Earnings Yield | -26.85% |
| Market Cap | 201.09M |
| PEGY Ratio | -0.0569 |